126 related articles for article (PubMed ID: 9702317)
1. Covalent linkage of recombinant hirudin to a novel ionic poly(carbonate) urethane polymer with protein binding sites: determination of surface antithrombin activity.
Phaneuf MD; Szycher M; Berceli SA; Dempsey DJ; Quist WC; LoGerfo FW
Artif Organs; 1998 Aug; 22(8):657-65. PubMed ID: 9702317
[TBL] [Abstract][Full Text] [Related]
2. Covalent linkage of recombinant hirudin to poly(ethylene terephthalate) (Dacron): creation of a novel antithrombin surface.
Phaneuf MD; Berceli SA; Bide MJ; Quist WC; LoGerfo FW
Biomaterials; 1997 May; 18(10):755-65. PubMed ID: 9158859
[TBL] [Abstract][Full Text] [Related]
3. Bioengineering of a novel small diameter polyurethane vascular graft with covalently bound recombinant hirudin.
Phaneuf MD; Dempsey DJ; Bide MJ; Szycher M; Quist WC; LoGerfo FW
ASAIO J; 1998; 44(5):M653-8. PubMed ID: 9804516
[TBL] [Abstract][Full Text] [Related]
4. In vivo assessment of a novel dacron surface with covalently bound recombinant hirudin.
Wyers MC; Phaneuf MD; Rzucidlo EM; Contreras MA; LoGerfo FW; Quist WC
Cardiovasc Pathol; 1999; 8(3):153-9. PubMed ID: 10722238
[TBL] [Abstract][Full Text] [Related]
5. Chemical and physical characterization of a novel poly(carbonate urea) urethane surface with protein crosslinker sites.
Phaneuf MD; Quist WC; LoGerfo FW; Szycher M; Dempsey DJ; Bide MJ
J Biomater Appl; 1997 Oct; 12(2):100-20. PubMed ID: 9399137
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a novel hirudin-coated polyester graft to physiologic flow conditions: hirudin bioavailability and thrombin uptake.
Berceli SA; Phaneuf MD; LoGerfo FW
J Vasc Surg; 1998 Jun; 27(6):1117-27. PubMed ID: 9652474
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of a recombinant hirudin-albumin complex.
Phaneuf MD; Ito RK; LoGerfo FW
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):641-5. PubMed ID: 7841322
[TBL] [Abstract][Full Text] [Related]
8. Covalent linkage of streptokinase to recombinant hirudin: a novel thrombolytic agent with antithrombotic properties.
Phaneuf MD; Ozaki CK; Johnstone MT; Loza JP; Quist WC; LoGerfo FW
Thromb Haemost; 1994 Apr; 71(4):481-7. PubMed ID: 8052967
[TBL] [Abstract][Full Text] [Related]
9. Thrombin inhibition by covalently bound hirudin.
Ito RK; Phaneuf MD; LoGerfo FW
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):77-81. PubMed ID: 1773001
[TBL] [Abstract][Full Text] [Related]
10. Modification of polyethylene terephthalate (Dacron) via denier reduction: effects on material tensile strength, weight, and protein binding capabilities.
Phaneuf MD; Quist WC; Bide MJ; LoGerfo FW
J Appl Biomater; 1995; 6(4):289-99. PubMed ID: 8589514
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic fluorescence changes and rapid kinetics of the reaction of thrombin with hirudin.
Jackman MP; Parry MA; Hofsteenge J; Stone SR
J Biol Chem; 1992 Aug; 267(22):15375-83. PubMed ID: 1639783
[TBL] [Abstract][Full Text] [Related]
12. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices.
Yang Z; Tu Q; Maitz MF; Zhou S; Wang J; Huang N
Biomaterials; 2012 Nov; 33(32):7959-71. PubMed ID: 22877639
[TBL] [Abstract][Full Text] [Related]
13. Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex.
Klement P; Du YJ; Berry L; Andrew M; Chan AK
Biomaterials; 2002 Jan; 23(2):527-35. PubMed ID: 11762330
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.
Biemond BJ; Friederich PW; Levi M; Vlasuk GP; Büller HR; ten Cate JW
Circulation; 1996 Jan; 93(1):153-60. PubMed ID: 8616922
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled r-hirudin as a measure of thrombin activity at, or within, the rabbit aorta wall in vitro and in vivo.
Hatton MW; Ross-Ouellet B
Thromb Haemost; 1994 Apr; 71(4):499-506. PubMed ID: 8052970
[TBL] [Abstract][Full Text] [Related]
16. Chemical degradation kinetics of recombinant hirudin (HV1) in aqueous solution: effect of pH.
Gietz U; Alder R; Langguth P; Arvinte T; Merkle HP
Pharm Res; 1998 Sep; 15(9):1456-62. PubMed ID: 9755900
[TBL] [Abstract][Full Text] [Related]
17. Development of infection resistant polyurethane biomaterials using textile dyeing technology.
Phaneuf MD; Bide MJ; Szycher M; Gale MB; Huang H; Yang JC; LoGerfo FW; Quist WC
ASAIO J; 2001; 47(6):634-40. PubMed ID: 11730202
[TBL] [Abstract][Full Text] [Related]
18. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP
Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171
[TBL] [Abstract][Full Text] [Related]
19. Binding and orientation of fibronectin on surfaces with collagen-related peptides. Student Research Award in the Masters Science Degree Candidate category, 27th annual meeting of the Society for Biomaterials, St. Paul, MN, April 24-29, 2001.
Klueh U; Goralnick S; Bryers JD; Kreutzer DL
J Biomed Mater Res; 2001 Sep; 56(3):307-23. PubMed ID: 11426429
[TBL] [Abstract][Full Text] [Related]
20. Coating of Dacron vascular grafts with an ionic polyurethane: a novel sealant with protein binding properties.
Phaneuf MD; Dempsey DJ; Bide MJ; Quist WC; LoGerfo FW
Biomaterials; 2001 Mar; 22(5):463-9. PubMed ID: 11214757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
